Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium

Journal of Microbiological Methods

Volumn 87, Issue 3, 2011, Pages 273-277

  Grekov, Igor ^a   Svobodová, Milena ^b   Nohýnková, Eva ^c   Lipoldová, Marie ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

Biphasic culture medium; Leishmania; Parasite infectivity; SNB 9

Indexed keywords

AGAR; SALINE NEOPEPTONE BLOOD 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; IN VITRO STUDY; INOCULATION; LEISHMANIA; LEISHMANIASIS; LIQUID CULTURE; NONHUMAN; PARASITE CULTIVATION; PARASITE ISOLATION; PARASITE VIRULENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROMASTIGOTE;

ANIMALS; CULTURE MEDIA; LEISHMANIA; LEISHMANIASIS; MICE; MICE, INBRED BALB C; PARASITOLOGY;

HEXAPODA; PROTOZOA; TRYPANOSOMA;

EID: 81055156601     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2011.08.012     Document Type: Article

References (28)

1. Chang K.-P., Fish W.R. Leishmania. In vitro cultivation of protozoan parasites 1983, 111-145. CRC Press, Boca Raton, Florida, USA. J.B. Jensen (Ed.).
2. da Silva R., Sacks D.L. Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect. Immun. 1987, 55:2802-2806.
3. De Oliveira C.I., Teixeira M.J., Gomes R., Barral A., Brodskyn C. Animal models for infectious diseases caused by parasites: leishmaniasis. Drug Discov. Today Dis. Models 2004, 1:81-86.
4. Demant P., Lipoldová M., Svobodová M. Resistance to Leishmania major in mice. Science 1996, 274:1392-1393.
5. Desjeux P. Leishmaniasis: public health aspects and control. Clin. Dermatol. 1996, 14:417-423.
6. Dey T., Afrin F., Anam K., Ali N. Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source, and strain of parasite. J. Eukaryot. Microbiol. 2002, 49:270-274.
7. Diamond L.S., Herman C.M. Incidence of trypanosomes in the Canada goose as revealed by bone marrow culture. J. Parasitol. 1954, 40:195-202.
8. Goto H., Lindoso J. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev. Anti Infect. Ther. 2010, 8:419-433.
9. Havelková H., Badalová J., Svobodová M., Vojtíšková J., Kurey I., Vladimirov V., Demant P., Lipoldová M. Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun. 2006, 7:220-233.
10. Kedzierski L. Leishmaniasis vaccine: where are we today?. J. Glob. Infect. Dis. 2010, 2:177-185.
11. Kobets T., Badalová J., Grekov I., Havelková H., Svobodová M., Lipoldová M. Leishmania parasite detection and quantification using PCR-ELISA. Nat. Protoc. 2010, 5:1074-1080.
12. Kurey I., Kobets T., Havelková H., Slapničková M., Quan L., Trtková K., Grekov I., Svobodová M., Stassen A.P., Hutson A., Demant P., Lipoldová M. Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection. Immunogenetics 2009, 61:619-633.
13. Lima H.C., Bleyenberg J.A., Titus R.G. A simple method of quantifying Leishmania in tissues of infected animals. Parasitol. Today 1997, 13:80-82.
14. Lipoldová M., Demant P. Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat. Rev. Genet. 2006, 7:294-305.
15. Lipoldová M., Svobodová M., Krulová M., Havelková H., Badalová J., Nohýnková E., Holáň V., Hart A.A.M., Volf P., Demant P. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunological phenotypes. Genes Immun. 2000, 1:200-206.
16. Lipoldová M., Svobodová M., Havelková H., Krulová M., Badalová J., Nohýnková E., Hart A.A.M., Schlegel D., Volf P., Demant P. Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics 2002, 54:174-183.
17. Merlen T., Sereno D., Brajon N., Rostand F., Lemesre J.-L. Leishmania spp.: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms. Am. J. Trop. Med. Hyg. 1999, 60:41-50.
18. Moore E.M., Lockwood D.N. Treatment of visceral leishmaniasis. J. Glob. Infect. Dis. 2010, 2:151-158.
19. Myskova J., Votypka J., Volf P. Leishmania in sand flies: comparison of quantitative polymerase chain reaction with other techniques to determine the intensity of infection. J. Med. Entomol. 2008, 45:133-138.
20. Sádlová J., Volf P., Victoir K., Dujardin J.C., Votypka J. Virulent and attenuated lines of Leishmania major: DNA karyotypes and differences in metalloproteinase GP63. Folia Parasitol. (Praha) 2006, 53:81-90.
21. Schuster F.L., Sullivan J.J. Cultivation of clinically significant hemoflagellates. Clin. Microbiol. Rev. 2002, 15:374-389.
22. Svobodová M., Bates P.A., Volf P. Detection of lectin activity in Leishmania promastigotes and amastigotes. Acta Trop. 1997, 68:23-35.
23. Svobodová M., Alten B., Zídková L., Dvorák V., Hlavacková J., Mysková J., Seblová V., Kasap O.E., Belen A., Votýpka J., Volf P. Cutaneous leishmaniasis caused by Leishmania infantum transmitted by Phlebotomus tobbi. Int. J. Parasitol. 2009, 39:251-256.
24. van Zandbergen G., Bollinger A., Wenzel A., Kamhawi S., Voll R., Klinger M., Müller A., Hülscher C., Herrmann M., Sacks D., Solbach W., Laskay T. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13837-13842.
25. Vladimirov V., Badalová J., Svobodová M., Havelková H., Hart A.A.M., Blažková H., Demant P., Lipoldová M. Different genetic control of cutaneous and visceral disease after Leishmania major infection in mouse. Infect. Immun. 2003, 71:2041-2046.
26. Volf P., Kiewegová A., Svobodová M. Sandfly midgut lectin: effect of galactosamine on Leishmania infections. Med. Vet. Entomol. 1998, 12:151-154.
27. Wanderley J.L., Pinto da Silva L.H., Deolindo P., Soong L., Borges V.M., Prates D.B., de Souza A.P., Barral A., Balanco J.M., do Nascimento M.T., Saraiva E.M., Barcinski M.A. Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of leishmaniasis. PLoS One 2009, 4:e5733.
28. WHO Manual of visceral leishmaniasis control. WHO/LEISH/96.40 1996, 52-53. World Health Organization, Geneva.